California’s Flavored Tobacco Ban Will Not Be Blocked by Supreme Court
TUESDAY, Dec. 13, 2022 (HealthDay News) -- An attempt to block California's flavored tobacco ban was stopped Monday when the Supreme Court declined to hear the case. That now means the ban will go into effect on Dec. 21.
The ban includes everything from candy flavors to menthol in a wide range of tobacco products, including vape pens, tank-based systems, chewing tobacco, and cigarettes. Exceptions include hookahs, some cigars, and loose-leaf tobacco, CBS News reported.
The ban has been in limbo for two years. It was first passed by the state legislature in 2020, then sent to the voters when tobacco companies gathered the signatures required for a vote to challenge the ban. But nearly two-thirds of voters approved the ban in November. The next day, R.J. Reynolds filed a lawsuit challenging the ban.
Tobacco companies have argued that banning flavored products is the role of the U.S. Food and Drug Administration. Losing the menthol flavor would cause a huge loss in business for tobacco companies because menthol cigarettes represent about one-third of the market in the large state, CBS News reported. Meanwhile, California has said that federal law allows state and local governments to choose what tobacco products are allowed within their boundaries.
California follows Massachusetts in its flavored tobacco ban. Several states have outlawed flavored vaping products. Even some cities have bans, including Los Angeles and San Diego, which also met with resistance.
In April, the FDA proposed a ban on the sale of menthol cigarettes. Ban supporters want to stop sharp increases in teen smoking and vaping. Although it is illegal for retailers to sell tobacco to anyone younger than 21 years, the products are still easy to obtain, supporters have said. Retailers who sell to minors could be fined up to $250 under the new ban, CBS News reported.
Related Posts
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important...
House Passes Bill To Limit Insulin Costs to $35 a Month
FRIDAY, April 1, 2022 (HealthDay News) – Americans who use insulin to control...
AAN: Atogepant Efficacious for Preventive Treatment of Migraine
FRIDAY, April 21, 2023 (HealthDay News) -- For adults with episodic migraine who...
Contact Tracing Shows No Transmission From Index Monkeypox Case
TUESDAY, Nov. 8, 2022 (HealthDay News) -- No secondary cases were observed in a...